Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Ixodes in SPA agreement with FDA on phase III trial of Ixogel to prevent Lyme disease

March 3, 2016

Microbion and Haisco enter agreement to develop and commercialize MBN-101

March 3, 2016

First-in-human study of oral antimalarial drug SJ-733

March 2, 2016

Polymorphism in galectin-3 lectin domain is associated with beta-lactam allergy

March 2, 2016

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents TLR7 agonists

March 2, 2016

Siemens to release genetic assay for early detection of Zika virus

March 2, 2016

Benitec to terminate HCV program

March 2, 2016

Shionogi and Roche sign license and collaboration agreement for anti-influenza drug

March 1, 2016

GeoVax and USAMRIID to collaborate on development of tetravalent hemorrhagic fever vaccine

March 1, 2016

EMA committee hands down positive opinion for Viekirax + Exviera label expansion

Feb. 29, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...